dc.contributor.author | Southgate, L | en_US |
dc.contributor.author | Machado, RD | en_US |
dc.contributor.author | Snape, KM | en_US |
dc.contributor.author | Primeau, M | en_US |
dc.contributor.author | Dafou, D | en_US |
dc.contributor.author | Ruddy, DM | en_US |
dc.contributor.author | Branney, PA | en_US |
dc.contributor.author | Fisher, M | en_US |
dc.contributor.author | Lee, GJ | en_US |
dc.contributor.author | Simpson, MA | en_US |
dc.contributor.author | He, Y | en_US |
dc.contributor.author | Bradshaw, TY | en_US |
dc.contributor.author | Blaumeiser, B | en_US |
dc.contributor.author | Winship, WS | en_US |
dc.contributor.author | Reardon, W | en_US |
dc.contributor.author | Maher, ER | en_US |
dc.contributor.author | FitzPatrick, DR | en_US |
dc.contributor.author | Wuyts, W | en_US |
dc.contributor.author | Zenker, M | en_US |
dc.contributor.author | Lamarche-Vane, N | en_US |
dc.contributor.author | Trembath, RC | en_US |
dc.date.accessioned | 2016-03-21T10:02:43Z | |
dc.date.available | 2011-04-20 | en_US |
dc.date.issued | 2011-05-13 | en_US |
dc.identifier.issn | 0002-9297 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/11530 | |
dc.description.sponsorship | This work was supported by grants from the British Heart Foundation (BHF) to R.C.T. (RG/08/006/25302), Wellcome Trust to E.R.M. and R.C.T. (078751/Z/05/Z), European Union Framework 6 award for PULMOTENSION (LSHM-CT-2005-018725), Canadian Institute of Health Research to N.L-V. (MOP-84449), and German Research Foundation to M.Z. (ZE 524/2-2). The authors acknowledge use of BRC Core Facilities provided by the financial support from the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. R.C.T. is a senior investigator at the NIHR. R.D.M. is a BHF Intermediate Research Fellow (FS/07/036). P.B. and M.F. are MRC career development fellows funded by the National Institute of Dental and Craniofacial Research (National Institutes of Health) Craniofacial Center Grant (P50 DE-16215-05). D.R.F. is a MRC senior clinician scientist. N.L-V. is a Fonds de la Recherche en Santé du Quebec chercheur-boursier senior. | en_US |
dc.format.extent | 574 - 585 | en_US |
dc.relation.ispartof | AM J HUM GENET | en_US |
dc.subject | RHO-GTPASES | en_US |
dc.subject | BETA-CATENIN | en_US |
dc.subject | CELL BIOLOGY | en_US |
dc.subject | ACTIVATION | en_US |
dc.subject | WNT | en_US |
dc.subject | LOCALIZATION | en_US |
dc.subject | EXPRESSION | en_US |
dc.subject | DEFECTS | en_US |
dc.subject | BINDING | en_US |
dc.subject | FAMILY | en_US |
dc.title | Gain-of-Function Mutations of ARHGAP31, a Cdc42/Rac1 GTPase Regulator, Cause Syndromic Cutis Aplasia and Limb Anomalies | en_US |
dc.type | Article | |
dc.rights.holder | Copyright © 2011 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved. | |
dc.identifier.doi | 10.1016/j.ajhg.2011.04.013 | en_US |
pubs.issue | 5 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 88 | en_US |